Background and objective The most important presentation of COVID-19 is hyper
inflammatory condition and cytokine storm that occurs due to excessive increase of the …

Abstract Coronavirus disease 2019 (COVID-19) and vaccination against severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) have been associated with autoimmune …

Objective The main aim of this study was to define the best treatment option for multisystem
inflammatory syndrome in children (MIS-C) and to analyse the role of anakinra. Methods …

Kawasaki Disease (KD) is one of the most common vasculitides in the pediatric population
and is encountered regularly by the general pediatrician. First described as an acute febrile …

Studies on the severity in multisystem inflammatory syndrome in children (MIS-C) show
heterogeneous results and may not reflect a global perspective. This systematic review aims …

Background. To describe the existing pharmacological managements for Multisystem
Inflammatory Syndrome in Children (MIS-C) in a systematic way, to identify the available …

Background Knowledge about multisystem inflammatory syndrome in children (MIS-C) is
evolving, and evidence-based standardised diagnostic and management protocols are …

Paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2
(PIMS-TS) is a systemic hyperinflammatory state described in children recently infected with …

This systematic review and meta-analysis were conducted to evaluate the prevalence of
cardiac manifestations associated with multisystem inflammatory syndrome in children …

Background: Although there is consensus to use immunoglobulins and corticosteroids as
first-line treatments for multisystem inflammatory syndrome in children (MIS-C), the …